HealthTech Bio Actives (HTBA) has today announced the acquisition of Specnova, a US biotechnology company specialised in next-generation ingredient delivery technologies to improve the bioavailability, performance and efficacy of plant compounds, vitamins, minerals, amino acids and peptides.
This is HTBA’s first acquisition and marks a strategic milestone for both companies, bringing together their complementary offerings. While both companies will continue to operate independently, following the agreement they will also work together to enhance and develop their science-backed ingredient portfolios for the supplement, food and beverage industries.
For HTBA, the acquisition creates exciting opportunities to strengthen its foothold in the US market, harnessing Specnova’s trailblasing ingredient delivery systems and scientific expertise to enhance product performance and develop differentiated formats over time.
Said Alexandre Valls-Coma, CEO of HTBA: “For almost 50 years, HTBA has been on a journey to deliver science-backed solutions centred on consumer-driven innovation to support people’s health and well being. This acquisition marks a major milestone for us, affirming our ongoing commitment to sustainable growth, by investing in advanced technologies that strengthen our portfolio for the long term. Specnova is a natural fit, bringing technologies that complement our existing offering and provide a catalyst to accelerate future developments. Together, we can combine our strengths to unlock new opportunities for our customers, while allowing both businesses to build on what we do best.”
Added Sebastian Balcombe, Founder and CEO of Specnova: “Specnova was created to bring true innovation and effectiveness to raw materials in the natural products industry. We have reached a point where the right partner could help us take the business to the next level. What stood out when we met HTBA was a shared commitment to science and to doing things properly from the outset. Our focus on technology, clinical research, intellectual property and customer service will not change. What changes is the scope of what we are able to offer, both to our existing customers in North America and to customers in markets where HTBA is already established.”
Both companies will exhibit at SupplySide Global 2026 (Las Vegas, 28-30 October), with HTBA at booth #3645 and Specnova at booth #5040. At this year’s exhibition, HTBA will mark the official US launch of Leanara®, an innovative GLP-1 companion ingredient that combines bioflavonoids with advanced vitamin B12 technology to help preserve muscle mass and sustain energy levels during weight loss. Visitors can also explore the company’s wider range of functional health ingredients including MecobalActive®, a bioidentical, active form of vitamin B12 for cognitive and physical performance, and DiosVein Forte®, a micronized flavonoid fraction developed to support vascular health, circulation and leg comfort.
Specnova will showcase its flagship delivery systems, LipoVantage® and NovaQSpheres® alongside its clinically backed branded ingredients range, including NooGandha®, liposomal ashwagandha, NordicCherry® tart cherry extract and RiboBeauty® redcurrant blackcurrant extract plus more. For more visit stand #3645 at SupplySide Global or htba.com
